The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 07, 2020

Filed:

Nov. 06, 2014
Applicant:

Gnosis Spa, Milan, IT;

Inventors:

Daniele Giovannone, Frosinone, IT;

Niccolò Miraglia, Desio, IT;

Marco Berna, Desio, IT;

Assignee:

GNOSIS SPA, Milan, IT;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/28 (2006.01); A61K 31/7076 (2006.01); A61K 31/519 (2006.01); A61K 9/20 (2006.01); A61K 31/205 (2006.01); A61K 31/714 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 9/2813 (2013.01); A61K 9/2095 (2013.01); A61K 9/282 (2013.01); A61K 9/288 (2013.01); A61K 31/205 (2013.01); A61K 31/519 (2013.01); A61K 31/7076 (2013.01); A61K 31/714 (2013.01); A61K 45/06 (2013.01); A61K 9/2893 (2013.01);
Abstract

The present invention relates to a slow-release solid oral nutraceutical and/or pharmaceutical composition comprising: a core containing a donor of methyl groups and at least one pharmaceutically acceptable excipient, and an outer coating containing shellac and/or a pharmaceutically acceptable salt thereof, magnesium stearate, and at least one pharmaceutically acceptable excipient. The coating of said solid oral composition allows the donor of methyl groups, preferably SAMe and/or a pharmaceutically acceptable salt thereof, to cross intact the gastric barrier and release the same in a continuous and complete manner along the entire digestive tract.


Find Patent Forward Citations

Loading…